Drugs -- Prices -- United States
Resource Information
The concept Drugs -- Prices -- United States represents the subject, aboutness, idea or notion of resources found in Jacksonville Public Library.
The Resource
Drugs -- Prices -- United States
Resource Information
The concept Drugs -- Prices -- United States represents the subject, aboutness, idea or notion of resources found in Jacksonville Public Library.
- Label
- Drugs -- Prices -- United States
118 Items that share the Concept Drugs -- Prices -- United States
Context
Context of Drugs -- Prices -- United StatesSubject of
No resources found
No enriched resources found
- Update : excessive Medicare reimbursement for ipratropium bromide
- A comparison of albuterol sulfate prices
- A prescription for savings : reducing drug costs to Medicare : hearing before the Special Committee on Aging, United States Senate, One Hundred Twelfth Congress, first session, Washington, DC, July 21, 2011
- Addition of qualified drugs to the Medicaid federal upper limit list
- Are Medicare allowances for Albuterol Sulfate reasonable?
- Assessment of sponsors' materials under the temporary Medicare-approved drug discount card program
- Average sales prices : manufacturer reporting and CMS oversight
- CBO's model of drug price negotiations under the Elijah E. Cummings Lower Drug Costs Now Act
- Calculation of volume-weighted average sales price for Medicare Part B prescription drugs
- Closing the coverage gap : Medicare prescription drugs are becoming more affordable
- Comparing drug reimbursement : Medicare and Department of Veterans Affairs
- Comparison of Medicaid federal upper limit amounts to average manufacturer prices
- Competition and the cost of Medicare's prescription drug program
- Coverage and pricing of drugs that can be covered under Part B and Part D : final report
- Creating and Restoring Equal Access to Equivalent Samples Act of 2019 : report (to accompany H.R. 965) (including cost estimate of the Congressional Budget Office)
- DOD and VA pharmacy : progress and remaining challenges in jointly buying and mailing out drugs : report to Congressional requesters
- Deficiencies in the 340B drug discount program's database
- Deficiencies in the oversight of the 340B drug pricing program
- Deficit Reduction Act of 2005 : impact on the Medicaid federal upper limit program
- Drug manufacturers' noncompliance with average manufacturer price reporting requirements
- Drug price disclosure to consumers : current legal authority and considerations for Congress
- Drug price disclosures and the first amendment
- Drug prices : the role of patents and regulatory exclusivities
- Drug prices paid by DOD and VA are, on average, lower than those certified to HCFA as best price
- Drug pricing : manufacturer discounts in the 340B program offer benefits, but federal oversight needs improvement : report to congressional committees
- Drug pricing : research on savings from generic drug use
- Drug pricing and the law : regulatory exclusivities
- Drug pricing in America : a prescription for change : hearing before the Committee on Finance, United States Senate, One Hundred Sixteenth Congress, first session
- Drug shortage crisis : lives are in the balance : hearing before the Subcommittee on Health Care, District of Columbia, Census, and the National Archives of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Twelfth Congress, first session, November 30, 2011
- Drug shortages : causes, FDA authority, and policy options
- Drug shortages : why they happen and what they mean : hearing before the Committee on Finance, United States Senate, One Hundred Twelfth Congress, first session, December 7, 2011
- Drug shortages, public health threat continues, despite efforts to help ensure product availability : report to congressional addressees
- Drug shortages, threat to public health persists, despite actions to help maintain product availability : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives
- Economic analysis of the causes of drug shortages
- Effects of using generic drugs on Medicare's prescription drug spending
- Examining fluctuations in average manufacturer prices
- Examining issues related to competition in the pharmaceutical marketplace : a review of the FTC report, generic drug entry prior to patent expiration : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, June 13 and October 10, 2002
- Excessive Medicare payments for prescription drugs
- Excessive Medicare reimbursement for Albuterol
- Excessive Medicare reimbursement for ipratropium bromide
- FDA and drug prices : facilitating access to generic drugs
- Fin de la interrupción de la cobertura
- Frequently asked questions about prescription drug pricing and policy
- Generic drug user fee amendments : accelerating patient access to generic drugs : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session ... January 28, 2016
- Generic substitution and prescription drug prices : economic effects of state drug product selection laws
- Higher rebates for brand-name drugs result in lower costs for Medicaid compared to Medicare Part D
- How inflated published prices affect drugs considered for the federal upper limit list
- Improvements to the food at home, shelter, and prescription drug indexes in the U.S. consumer price index
- Improving drug pricing transparency and lowering prices for American consumers : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, May 21, 2019
- Is the U.S Department of Veterans Affairs meeting the pharmaceutical needs of veterans? : hearing before the Subcommittee on Health of the Committee on Veterans' Affairs, U.S. House of Representatives, One Hundred Eleventh Congress, first session, September 22, 2009
- Las apariencias engañan : la medicina que usted compra fuera de los Estados Unidos puede ser peligrosa y deficiente
- Less than half of Part D sponsors voluntarily reported data on potential fraud and abuse
- Limitations in manufacturer reporting of average sales price data for Part B drugs
- Looks can be deceiving : the medicine you buy from outside the United States may be unsafe or ineffective
- Making health care more affordable : lowering drug prices and increasing transparency : hearing before the Subcommittee on Health, Employment, Labor and Pensions, Committee on Education and Labor, U.S. House of Representatives, One Hundred Sixteenth Congress, first session : hearing held in Washington, DC, September 26, 2019
- Manufactured crisis : how devastating drug price increases are harming America's seniors
- Manufacturer safeguards may not prevent copayment coupon use for Part D drugs
- Medicaid brand-name drugs : rising prices are offset by manufacturer rebates
- Medicaid drug price comparisons : average manufacturer price to published prices
- Medicaid drug rebate dispute resolution could be improved
- Medicaid's use of revised average wholesale prices
- Medicare : comments on CMS proposed 2006 rates for specified covered outpatient drugs and radiopharmaceuticals used in hospitals
- Medicare : drug purchase prices for CMS consideration in hospital outpatient rate-setting
- Medicare : information on highest-expenditure Part B drugs : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives
- Medicare : payments for covered outpatient drugs exceed providers' cost
- Medicare Part B drugs : CMS data source for setting payments is practical but concerns remain : testimony before the Subcommittee on Health, Committee on Ways and Means, House of Representatives
- Medicare Part B drugs : program payments should reflect market prices
- Medicare Part B, CMS should take additional steps to verify accuracy of data used to set payment rates for drugs : report to the Ranking Member, Committee on Ways and Means, House of Representatives
- Medicare Part D coverage gap : discount program effects and brand-name drug price trends : report to congressional requesters
- Medicare Part D, prescription drug benefit : increasing use and access of affordable prescription drugs : a report of the Special Committee on Aging, United States Senate
- Medicare drug reimbursements : a broken system for patients and taxpayers : joint hearing before the Subcommittee on Health and the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, September 21, 2001
- Medicare hospital pharmaceuticals : survey shows price variation and highlights data collection lessons and outpatient rate-setting challenges for CMS : report to congressional committees
- Medicare payments for currently covered prescription drugs : hearing before the Subcommittee on Health of the Committee on Ways and Means, House of Representatives, One Hundred Seventh Congress, second session, October 3, 2002
- Medicare prescription drug benefit : review and oversight : hearing before the Committee on Finance, United States Senate, One Hundred Tenth Congress, first session, May 8, 2007
- Medicare reimbursement for lupron
- Medicare reimbursement of albuterol
- Memorandum report : Medicare Part D pharmacy discounts for 2008
- Monitoring Medicare Part B drug prices : a comparison of average sales prices to average manufacturer prices
- Outpatient prescribed medicines : a comparison of use and expenditures, 1987 and 2001
- Outpatient prescription medicines : a comparison of expenditures by household-reported condition, 1987 and 2001
- Pay to delay : are patent settlements that delay generic drug market entry anticompetitive? : hearing before the Subcommittee on Courts and Competition Policy of the Committee on the Judiciary, House of Representatives, One Hundred Eleventh Congress, first session, June 3, 2009
- Pharmaceutical prices and draft legislation on homeless veterans' programs and issues related to Persian Gulf War illness : hearing before the Subcommittee on Health of the Committee on Veterans' Affairs, House of Representatives, One Hundred Fifth Congress, first session, July 10, 1997
- Policy implications of pharmaceutical importation for U.S. consumers : hearing before the Subcommittee on Interstate Commerce, Trade, and Tourism of the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Tenth Congress, first session, March 7, 2007
- Prescription drug discount coupons and patient assistance programs (PAPs)
- Prescription drug issues in the Department of Veterans Affairs : hearing before the Committee on Veterans' Affairs, United States Senate, One Hundred Seventh Congress, first session, July 24, 2001
- Prescription drug pricing and negotiation : overview and economic perspectives for the Medicare prescription drug benefit : hearing before the Committee on Finance, United States Senate, One Hundred Tenth Congress, first session, January 11, 2007
- Prescription drug shortages : examining a public health concern and potential solutions : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Twelfth Congress, first session ... December 15, 2011
- Prescription drugs : out-of-pocket expenses and unmet need relative to family income, 2002
- Prescription drugs : oversight of drug pricing in federal programs : testimony before the Committee on Oversight and Government Reform, House of Representatives
- Prescription drugs : prices available through discount cards and from other sources
- Preserve Access to Affordable Generics and Biosimilars Act : report together with additional views (to accompany H.R. 2375) (including cost estimate of the Congressional Budget Office)
- Prices for brand-name drugs under selected federal programs
- Purple Book Continuity Act of 2019 : report (to accompany H.R. 1520) (including cost estimate of the Congressional Budget Office)
- Replacing average wholesale price : Medicaid drug payment policy
- Seniors feeling the squeeze : rising drug prices and the Part D program : hearing before the Special Committee on Aging, United States Senate, One Hundred Eleventh Congress, second session, Washington, DC, March 17, 2010
- Short-supply prescription drugs : shining a light on the gray market : hearing before the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Twelfth Congress, second session, July 25, 2012
- Special report of the U.S. Senate Special Committee on Aging on the sudden price spikes in off-patent prescription drugs : the monopoly business model that harms patients, taxpayers, and the U.S. health system
- State of competition in the pharmacy benefits manager and pharmacy marketplaces : hearing before the Subcommittee on Regulatory Reform, Commercial and Antitrust Law of the Committee on the Judiciary, House of Representatives, One Hundred Fourteenth Congress, first session, November 17, 2015
- States' collection of offset and supplemental Medicaid rebates
- States' use of new drug pricing data in the Medicaid program
- Strategies used by adults aged 18-64 to reduce their prescription drug costs, 2017
- Suppliers' acquisition costs for albuterol sulfate
- The CREATES Act of 2019 and lowering drug prices : legal background and overview
- The big fix : how the pharmaceutical industry rips off American consumers
- The cost of prescription drugs : how the drug delivery system affects what patients pay : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fifteenth Congress, first session on the cost of prescription drugs : focusing on how the drug delivery system affects what patients pay
- The effect of generic drug competition on generic drug prices during the Hatch-Waxman 180-day exclusivity period
- The opioid epidemic and the U.S. labor market
- The other drug war
- The truth about the drug companies : how they deceive us and what to do about it
- The truth about the drug companies : how they deceive us and what to do about it
- Things to think about when you compare Medicare drug coverage
- Through the looking glass : return to PPV : hearing before the Committee on Veterans' Affairs, U.S. House of Representatives, One Hundred Twelfth Congress, second session, Wednesday, June 6, 2012
- Top 10 outpatient prescription medicines ranked by utilization and expenditures for the U.S. community population, 2002
- Top 10 outpatient prescription medicines ranked by utilization and expenditures for the near elderly in the U.S. community population, 2002
- Treating the opioid epidemic : the state of competition in the markets for addiction medication : hearing before the Subcommittee on Regulatory Reform, Commercial and Antitrust Law of the Committee on the Judiciary, House of Representatives, One Hundred Fourteenth Congress, second session, September 22, 2016
- Trends in brand name and generic prescribed medicine utilization and expenditures, 1999 to 2003
- Unsustainable drug prices : hearing before the Committee on Oversight and Reform, House of Representatives
- Update : excessive Medicare reimbursement for albuterol
Embed
Settings
Select options that apply then copy and paste the RDF/HTML data fragment to include in your application
Embed this data in a secure (HTTPS) page:
Layout options:
Include data citation:
<div class="citation" vocab="http://schema.org/"><i class="fa fa-external-link-square fa-fw"></i> Data from <span resource="http://link.jaxpubliclibrary.org/resource/WweEHPUlCLs/" typeof="CategoryCode http://bibfra.me/vocab/lite/Concept"><span property="name http://bibfra.me/vocab/lite/label"><a href="http://link.jaxpubliclibrary.org/resource/WweEHPUlCLs/">Drugs -- Prices -- United States</a></span> - <span property="potentialAction" typeOf="OrganizeAction"><span property="agent" typeof="LibrarySystem http://library.link/vocab/LibrarySystem" resource="http://link.jaxpubliclibrary.org/"><span property="name http://bibfra.me/vocab/lite/label"><a property="url" href="http://link.jaxpubliclibrary.org/">Jacksonville Public Library</a></span></span></span></span></div>
Note: Adjust the width and height settings defined in the RDF/HTML code fragment to best match your requirements
Preview
Cite Data - Experimental
Data Citation of the Concept Drugs -- Prices -- United States
Copy and paste the following RDF/HTML data fragment to cite this resource
<div class="citation" vocab="http://schema.org/"><i class="fa fa-external-link-square fa-fw"></i> Data from <span resource="http://link.jaxpubliclibrary.org/resource/WweEHPUlCLs/" typeof="CategoryCode http://bibfra.me/vocab/lite/Concept"><span property="name http://bibfra.me/vocab/lite/label"><a href="http://link.jaxpubliclibrary.org/resource/WweEHPUlCLs/">Drugs -- Prices -- United States</a></span> - <span property="potentialAction" typeOf="OrganizeAction"><span property="agent" typeof="LibrarySystem http://library.link/vocab/LibrarySystem" resource="http://link.jaxpubliclibrary.org/"><span property="name http://bibfra.me/vocab/lite/label"><a property="url" href="http://link.jaxpubliclibrary.org/">Jacksonville Public Library</a></span></span></span></span></div>
